Suppr超能文献

心脏移植患者中开放式胃造瘘管与经皮内镜下胃造瘘管的比较。

Comparing open gastrostomy tube to percutaneous endoscopic gastrostomy tube in heart transplant patients.

作者信息

Ambur Vishnu, Taghavi Sharven, Jayarajan Senthil, Gaughan John, Toyoda Yoshiya, Dauer Elizabeth, Sjoholm Lars Ola, Pathak Abhijit, Santora Thomas, Goldberg Amy J

机构信息

Temple University School of Medicine, Department of Surgery, Philadelphia, PA, USA.

Temple University School of Medicine, Biostatistics Consulting Center, Philadelphia, PA, USA.

出版信息

Ann Med Surg (Lond). 2016 Mar 19;7:71-4. doi: 10.1016/j.amsu.2016.03.023. eCollection 2016 May.

Abstract

INTRODUCTION

Impaired wound healing due to immunosuppression has led some surgeons to preferentially use open gastrostomy tube (OGT) over percutaneous gastrostomy tube (PEG) in heart transplant patients when long-term enteral access is deemed necessary.

METHODS

The National Inpatient Sample (NIS) database (2005-2010) was queried for all heart transplant patients. Those receiving OGT were compared to those treated with PEG tube.

RESULTS

There were 498 patients requiring long-term enteral access treated with a gastrostomy tube, with 424 (85.2%) receiving a PEG and 74 (14.8%) an OGT. The PEG cohort had higher Charlson comorbidity Index (4.1 vs. 2.0, p = 0.002) and a higher incidence of post-operative acute renal failure (31.5 vs. 12.7%, p = 0.001). Post-operative mortality was not different when comparing the two groups (13.8 vs. 6.1%, p = 0.06). On multivariate analysis, while both PEG (OR: 7.87, 95%C.I: 5.88-10.52, p < 0.001) and OGT (OR 5.87, 95%CI: 2.19-15.75, p < 0.001) were independently associated with mortality, PEG conferred a higher mortality risk.

CONCLUSIONS

This is the largest reported study to date comparing outcomes between PEG and OGT in heart transplant patients. PEG does not confer any advantage over OGT in this patient population with respect to morbidity, mortality, and length of stay.

摘要

引言

由于免疫抑制导致伤口愈合受损,一些外科医生在认为有必要进行长期肠内营养通路时,更倾向于在心脏移植患者中使用开放式胃造口管(OGT)而非经皮胃造口管(PEG)。

方法

查询国家住院患者样本(NIS)数据库(2005 - 2010年)中的所有心脏移植患者。将接受OGT的患者与接受PEG管治疗的患者进行比较。

结果

有498例需要长期肠内营养通路的患者接受了胃造口管治疗,其中424例(85.2%)接受了PEG,74例(14.8%)接受了OGT。PEG组的查尔森合并症指数更高(4.1对2.0,p = 0.002),术后急性肾衰竭的发生率更高(31.5%对12.7%,p = 0.001)。两组术后死亡率无差异(13.8%对6.1%,p = 0.06)。多因素分析显示,虽然PEG(比值比:7.87,95%置信区间:5.88 - 10.52,p < 0.001)和OGT(比值比5.87,95%置信区间:2.19 - 15.75,p < 0.001)均与死亡率独立相关,但PEG的死亡风险更高。

结论

这是迄今为止报道的比较心脏移植患者中PEG和OGT治疗效果的最大规模研究。在该患者群体中,PEG在发病率、死亡率和住院时间方面并不比OGT有任何优势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验